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Chloromethyl methyl ether (CMME) has been used extensively as a crosslinking agent
for ion-exchange resins. Commercial grades of CMME are contaminated to the extent
of 2-8% with bischloromethyl ether, an alkylating agent which has been shown to be
a very potent lung carcinogen in animals. Reports by other investigators in this and
other countries have implicated CMME as a lung carcinogen in chemical workers.
The purpose of the study reported here was to examine the lung cancer mortality
experience with respect to intensity and duration of exposure in six of the seven
chemical companies that account for virtually all of the CMME use in the United States
The study included about 1800 workers who were exposed in the period 1948 to 1972
and abobut 8000 workers not exposed to CMME from the same plants who served as
controls. Exposed workers were characterized according to job description and duration
of exposure. In several plants the intensity of exposure was numerically graded for
each job category with adjustment for temporal changes in the plant processes. Social
Security records were used to identify deaths among workers who had left the companies
and death certificates have been obtained for virtually all known deaths. The age-
adjusted death rate for respiratory cancer in the CMME exposed group as a whole was
2.5 times that in the control group, whereas death rates due to other causes were
comparable. There was also a gradation of lung cancer risk according to intensity and
duration of exposure and the time elapsed since the onset of exposure.
Although the alkylating agent, chloromethyl
methyl ether (CMME), has been produced and
used in this country since shortly after World
War II as a crosslinking agent for ion-exchange
resins and as an intermediate in the produc-
tion of organic chemicals, it was not until 20
years later that its carcinogenic potential was
demonstrated in animals. Beginning in 1968,
Van Duuren et al. (1,2) reported that CMME
was carcinogenic for the mouse skin, and that
bischloromethyl ether (BCME), which is an
impurity (2-8%o) in commercial CMME, was
an even more potent carcinogen.
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Since occupational exposures to CMME and
BCME were primarily respiratory, an inhala-
tion study was done on rats and hamsters which
demonstrated the high potency of BCME for
the production of bronchogenic carcinoma and
esthesioneuroepitheliomas, even at the very
low exposure concentration of 0.1 ppm (5).
These findings prompted the follow-up study
reported here of workers exposed to CMME
and BCME which included six of the seven
major producers and users of CMME in the
United States; the seventh was studied by in-
vestigators from the National Institute for
Occupational Safety and Health (4). Since
these studies were initiated reports of exces-
sive lung cancer mortality among CMME-
exposed workers have appeared from this coun-
try as well as Germany and Japan (5-7). The
June 1975 209i14 cases reported by Figueroa (6) were in-
dependently identified in this study.
Methods
The components of this study included the
identification of all workers exposed to CMME
in the six firms; the quantification of exposure
intensity and duration in several plants; and
the selection of a control group of workers at
each plant. The Social Security Administra-
tion (SSA) files were searched for death rec-
ords on all workers whose vital status was
unknown. Death certificates were obtained on
all decedents. Company records were obtained
on all past and present employees with known
exposure to CMME. The study was confined to
males because there were fewer than ten
CMME-exposed females. Information was ob-
tained on each worker according to sequential
job categories and the associated employment
periods for each type of job within the company.
A control group of workers not exposed to
CMME was also selected at five of the six
firms. The sixth firm had no unexposed males
to use as controls. The control group was
selected at each firm from among those em-
ployed during the time period of exposure for
CMME workers and was unselected with re-
spect to specific type of work performed.
In three companies, it was possible to rank
the intensity of exposure according to job
description. This was done in conference with
the production engineers, supervisors and man-
agement personnel. The plant processes were
reviewed in detail with particular regard to
changes made over the years that had obvious
effects on the level of exposure. The consensus
approach was used to assign an exposure grade
of 0.1, 1, 2, 3, 4, 5, or 6 to each job category at
various periods of CMME use. It was not possi-
ble to assign absolute levels of exposure to any
of the grades or to define the relative differ-
ences in intensity of exposure between grades
or between different companies. Only one plant
had quantitative measures of CMME air levels,
and these were mostly recent.
The vital status of the workers at the end of
1972 was determined through Social Security
records for all those not employed, pensioned or
known dead by the companies as of the terminal
date. The SSA provided the date of death and
the geographical location at death if known;
otherwise the last known state of employment
or residence was given. As a check on the com-
pleteness of SSA records, a sample of about
300 known deaths from two flrms was included
in the request sent to the SSA.
Death certificates were provided by the firms
for most who had died while active employees
or pensioners of the firms. Death certificates
have been obtained for most of the remaining
deaths by requests to local and state bureaus of
vital statistics. When a death certificate could
not be found in the state listed by the SSA,
neighboring states and the state in which the
worker obtained his social security number were
tried. If these failed, a request was made to
the SSA to search for further information on
the place of death in their records. Death certifi-
cates have now been obtained for 97%o of the
known deaths. The causes of death are also
being verified from hospital and physician
records.
For this report, analyses of deaths were con-
fined to respiratory cancer, other cancer, and
other causes. Person-years at risk by attained
age were used for comparisons of the mortality
experience oftheCMME-exposed and unexposed
workers. The exposed workers entered the table
of person-years at risk 1 yr after first exposure
and the control workers entered 1 yr after first
employment or the date at which CMME was
initially used elsewhere in the company, which-
ever was later. A person remained at risk until
date of death or January 1, 1973. A person
who was first employed in 1972 or first exposed
to CMME in 1972 did not enter the person-
years analyses. The comparisons were adjusted
for age in 5-yr groupings.
Results
The number of CMME-exposed and control
employees in the study from the six plants is
shown in Table 1. The table also shows the
status of the workers as of the end of 1972.
About half were still employed at the firms.
About 98% of the exposed and control groups
were white, so race was not considered in these
analyses.
The check of the completeness of the SSA
death records revealed that 94% were correctly
identified by the SSA. There were no differ-
ences between the two firms whose names of
deceased workers were submitted; the SSA
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% Employed % Pensioned % Separated-Living % Dead Total number Firm
E C E C E C E C E C
1 55a 39 4 5 31 47 10 9 700 1819
2 70 55 6 20 21 9 3 16 204 6411
3 89 52 0 1 10 35 1 12 129 289
4 13 0 86 1 204 0
5 20 15 7 0 67 78 6 7 492 81
6 62 40 2 3 35 56 2 1 65 279
Total % 45 51 4 15 45 20 6 14
Total number 805 4519 76 1348 807 1753 106 1259 1794 8879
a Per cent of the total exposed or control group, respectively, at the indicated firm.
Table 2. Person-years at risk by attained age for total
elapsed years and for five or more elapsed years since entry
into study.
1-25 elapsed 5-25 elapsed
years years
Attained age
Exposed, Control, Exposed, Control,
15-24 6.0 3.2 0.7 0.5
25-29 12.7 7.9 7.2 4.4
30-34 16.0 11.7 14.8 10.1
35-39 17.2 14.6 18.4 14.6
40-44 16.3 16.0 18.9 17.1
45-49 12.8 14.5 15.6 16.2
50-54 8.5 11.6 10.9 13.1
55-59 5.3 8.7 6.8 9.8
60-64 2.8 5.9 3.6 6.9
65-69 1.4 3.5 1.9 4.3
70-79 0.8 2.3 1.1 2.8
80-99 0.2 0.1 0.2 0.1
Total 100 100 100 100
Total person-
years 21,418 171,454 14,845 136,301
recovered 94%7 from each firm, thus suggesting
there is probably no bias in the rates of detect-
ing deaths among the firms. The data were
further checked for biases due to temporal
factors (year of death), age at death, and race,
but none were found (chi-square tests, p >0.50
for all comparisons).
Table 2 presents the number of person-years
at risk by attained age in the exposed and con-
trol groups. The age distribution of the con-
trols is generally older than that of the exposed
group, and this accounts for the fact, shown in
Table 1, that 6% of the exposed group but
14% of the control group have died.
Only deaths for which the cause of death has
been ascertained are included in the analyses.
Age-adjusted rates were calculated based on
Table 3. Noncancer deaths by age for all workers.
Age CMME-exposed Control
Deaths Rate/ Deaths Rate/
1000/yr 1000/yr
15-24 3 2.3 3 0.5
25-29 1 0.4 8 0.6
30-34 4 1.2 17 0.8
35-39 5 1.4 32 1.3
40-44 8 0.3 43 1.6
45-49 11 4.0 90 3.6
50-54 7 3.8 104 5.2
55-59 8 7.1 124 8.4
60-64 11 18.3 126 12.4
65-69 7 23.8 173 29.2
70-79 6 34.9 172 44.5
80-99 0 18 113.2
Total 71 910
Age-adjusted
rate/1000/yr 3.31 3.35
the age distribution of the exposed group. This
was done to make the control group more com-
parable with the exposed workers, who con-
tributed a considerably smaller proportion of
person-years beyond the age of 60. Had the
control group been used for the age weighting,
it would have given considerable weight to the
older ages, which were largely irrelevant to
the experience of the exposed group.
As shown in Table 3, the two groups had
essentially identical death rates due to causes
other than cancer, the age-adjusted yearly
death rates per 1000 being 3.31 in the CMME-
exposed group and 3.35 in the control group.
The age-adjusted death rates from cancer
were calculated after excluding the first 4 yr
elapsed after initial exposure (or after entry
into the study for the control group), in order
to avoid inclusion of a large number of exposed
June 1975 211cases or person-years who would have had in-
sufficient time to develop cancer. The age-
adjusted yearly death rates for all malignant
neoplasms other than primary cancer of the
respiratory tract were 0.54 and 0.99 per 1000,
respectively, as shown in Table 4. The age-
specific relative risks between the two groups
fluctuated so from one age to another, that the
overall difference in nonrespiratory cancer can-
not be considered meaningful.
The death rates due to respiratory cancer are
shown in Table 5. There were a total of 22
respiratory cancer cases of which 20 were
bronchogenic, one was laryngeal and the other
mediastinal. The age-adjusted rates were 1.48
in the CMME-exposed group and 0.59 in the
control group, and the relative risk adjusted
for age (8) was 2.53.
At Firm 1, which had the largest number of
CMME-exposed employees and most of the
respiratory cancer deaths among exposed em-
ployees, the age-adjusted relative risk was 2.48
and the rates, -shown in Table 6, were 2.40 in
the exposed group and 0.97 among controls.
Each person-year contributed by CMME-
exposed workers at Firm 1 was characterized
by a cumulative exposure score, defined as the
sum across all exposure periods up to the
middle of that year of the exposure intensity
score times the duration, as well as attained
age and elapsed years since first exposure. This
permitted the calculation of age-adjusted res-
piratory cancer death rates by cumulative ex-
posure experience for workers having at least
5 yr elapsed since first exposure. Each worker
Table 4. Nonrespiratory cancer deaths by age for workers
with >5 yr elapsed since entry into the study.
CMME-exposed Control
Age
Deaths Rate/ Deaths Rate/
1000/yr 1000/yr
30-34 0 2 0.1
85-39 0 - 4 0.2
40-44 0 - 12 0.5
45-49 0 - 16 0.7
50-54 1 0.6 25 1.4
55-59 4 4.0 23 1.7
60-64 0 43 4.6
65-69 1 3.6 36 6.1
70-79 1 . 6.2 40 10.4
80-99 1 29.4 5 31.4
Total 8 206
Age-adjusted rate/
1000/yr 0.54 0.99
Table 5. Respiratory cancer deaths by age for workers
with >5 yr elapsed since entry into the study.
CMME-exposed Control
Age
Deaths Rate/ Deaths Rate/
1000/yr 1000/yr
30-34 1 0.5 0
35-39 3 1.1 3 0.2
40-44 2 0.7 5 0.2
45-49 3 1.3 14 0.6
50-54 8 5.0 19 1.1
55-59 3 3.0 18 1.3
60-64 0 18 1.9
65-69 2 7.2 15 2.5
70-79 0 29 7.5
80-99 0 1 6.3
Total 22 122
Age-adjusted rate/
1000/yr 1.48 0.59
Table 6. Respiratory cancer deaths by age for workers of
Firm 1 with >5 yr elapsed since entry into the study.
CMME-exposed Control
Age
Deaths Rate/ Deaths Rate/
1000/yr 1000/yr
30-34 1 0.9 0
35-39 3 2.1 2 0.6
40-44 2 1.2 0
45-49 3 2.1 5 1.8
50-54 7 7.0 4 1.9
55-59 3 5.4 2 1.5
60-64 0 3 3.7
65-69 0 3 5.8
70-79 0 2 6.0
Total 19 21
Age-adjusted rate/
1000/yrs 2.40 0.97
a Adjusted to the exposed group at Firm 1.
was also assigned his final cumulative exposure
score so that the percentage of respiratory
cancer deaths at each exposure level could be
calculated. The results are shown in Table 7.
There is a clear dose-response relationship
between CMME exposure and respiratory
cancer.
For further analysis the exposed workers of
Firm 1 were grouped into light, medium, and
heavy "maximum intensity of exposure" groups
-classified by duration of maximum exposure
and elapsed years since first exposure-based
on their total work experience as shown in
Table 8. Similar assignments of person-years
by age were also made; here each person-year
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tained to the middle of that year. All 19 res-
piratory cancer deaths occurred in those who
had been subjected to heavy exposure with 5 yr
or more since the onset of exposure; the pro-
portion of workers who died of respiratory
cancer increased with the duration of heavy-
intensity exposure. The age-adjusted death
rates showed a similar increase with duration
of exposure.
Cumulative mortality-corrected probabilities
of death due to lung cancer for both the non-
exposed and BCME-exposed workers at Firm
1 with X± 5 yr elapsed since entry into the study
(Table 6) and for United States white males
Table 7. Respiratory cancer deaths among CMME-
exposed workers of Firm 1 with >5 yr elapsed since first
exposure by cumulative exposure experience.
Weighted Lung cancer Age-
cumulative Persons deaths adjusted
exposure rate/
scorea No. % 1000/yrb
20-50 40 9 23.1 23.8
12-20 60 3 5.0 2.4
8-12 61 4 6.6 3.5
5-8 57 1 1.8 1.1
3-5 73 1 1.4 1.2
<3 339 1 0.3 0.3
Total 630 19 3.0
* 2 exposure scoreXyears of exposure.
b Adjusted to the total exposed group at Firm 1.
(9) are plotted on lognormal probability paper
as shown in Figure 1. The three lines drawn
by eye-fit are parallel supporting the notion
that exposure to BCME shortens the time to
lung cancer development by a constant factor,
roughly 15-20%go with respect to the non-
exposed workers.
Discussion
There is now considerable evidence that
BCME and/or CMME are respiratory carcino-
gens in humans. In this study the relative risk
of respiratory cancer for all exposed workers
with at least 5 yr elapsed since onset of expo-
sure was 2.5. For those with the heaviest expo-
sure at Firm 1 (12 workers) the relative risk
was over 20, i.e., age-adjusted death rate/1000/
yr of 23.0 compared to 0.97 for controls; 25%o
of the most heavily exposed workers (3/12)
developed respiratory cancer. A dose-response
relationship was also clearly evident.
One distinctive feature of the respiratory
cancer experience of the exposed group was the
early age at onset. As shown in Table 5, 77%
of the respiratory cancers occurred before age
55, whereas if the United States white male
rates of respiratory cancer (9) are applied
to the age-specific person-years at risk in the
exposed group, one would expect only 43%o to
have occurred that early in life. Figure 1 also
Table 8. Respiratory cancer deaths among CMME-exposed workers of Firm 1
by duration and intensity of maximum exposure.
Intensity of Total dur- Distribution of Workers by elapsed time since Total for >5 yr maximum ation of first exposures elapsed
exposure maximum
(score) exposure, yr 0-4 yr 5-9 yr 10-14 yr 15-25 yr 25 (%) Age-Adj.
Rate/
1000/yrb
Heavy (4-6) >5 0 1/1 1/1 1/10 3/12 23.0
(25) 1-5 0 2/3 4/15 6/73 12/91 8.7
(13) <1 0 80 27 4/153 4/188 1.5
(2.1)
Medium (2, 3) >5 0 0 0 10 0/10 1-5 0 11 1 65 0/77
<1 0 18 9 85 0/112 Low (0.1,1) >5 0 1 1 2 0/4
1-5 17 13 2 10 0/25
<1 52 28 42 41 0/111
Numerator is number of deaths; denominator is number of workers.
b Adjusted to the total exposed group at Firm 1.
e Number of workers is given in cells with no deaths.
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FIGURE 1. Cumulative mortality-corrected probabilities
of lung cancer death for BCME-exposed and non-
exposed workers at Firm 1 with
- 5 yr elapsed
since entry into the study and for U.S. white males
plotted on lognormal probability paper (lines drawn
by eye-fit).
clearly shows the life-shortening effects of
CMME exposure with respect to lung cancer.
A calculation of the expected years of life lost
due to respiratory cancer (10) among the 103
workers at Firm 1 with at least 1 yr of heavy
exposure (see Table 8) shows that the workers
have lost 3.8 yr of life, on the average. If all
291 workers with some heavy exposure are
included, the average life-shortening is 1.6 yr.
Those who died of respiratory cancer lost an
average of 25 yr of life.
The data presented in Table 8 demonstrate
that BCME and/or CMME are human respira-
tory carcinogens within 25 yr of initial expo-
sure if the exposure was very intense. However,
it will be important to determine whether fur-
ther years of follow-up will reveal excessive
respiratory cancers in those with lower expo-
sure. An inverse relationship between dose and
the length of the latent period is suggested by
the observation that the group with heavy
exposure of less than one year duration had
the longest average latent period.
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